Edward Nirenberg

I think we need a well-designed RCT of Sotrovimab vs. current Omicron variants immediately

Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants https://www.biorxiv.org/content/10.1101/2023.01.17.523798v1

Jan 17, 2023 at 10:02pmWeb
Show threadEdward NirenbergJan 17, 2023

Tweetorial on the study from @veeslerlab here:

---
RT @veeslerlab
Curious about #COVID19 #SARSCoV2 therapeutic antibodies, bivalent vaccines & immune imprinting?

Here is our latest work on these topics in collaboration with @DavideCorti6 @msdiamondlab

Led by @AminAddetia @LucaPiccoli9 Brett Case @YoungjunPark11

1/
https://www.biorxiv.org/content/10.1101/2023.01.17.523798v1
https://twitter.com/veeslerlab/status/1615474603983523840

Show threadBen PierceJan 17, 2023
@enirenberg impressive study - it's rare to see passive and active antibodies together in one paper